That compares with up to 16% from Novo Nordisk’s Wegovy, and up to 22.5% from Eli Lilly’s rival Mounjaro when administered alongside lifestyle interventions such as improved diet, exercise and sleep.
Novo Nordisk has launched Wegovy – its popular weight loss treatment – in China. China, with a population of 1.4 billion, has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback